{
    "clinical_study": {
        "@rank": "142956", 
        "arm_group": [
            {
                "arm_group_label": "closed vitrification with closed storage", 
                "arm_group_type": "Active Comparator", 
                "description": "Half of the oocytes of every donor will be vitrified with the Cryo Bio Systems High Security vitrification (CBSvit HS) device; the standard device in our lab."
            }, 
            {
                "arm_group_label": "open vitrification with closed storage", 
                "arm_group_type": "Experimental", 
                "description": "Half of the oocytes of every donor will be vitrified with the Cryotop closed system (Cryotop SC)."
            }
        ], 
        "brief_summary": {
            "textblock": "Donor sibling oocytes will be vitrified with two commercialy available devices. The first\n      device is closed vitrification with closed storage and the second device is open\n      vitrification with closed storage. Oocyte acceptors receive oocytes from both devices. With\n      the increase in cooling rate generated by the open vitrification (second device), we expect\n      to get an increase in survival rate of 10%."
        }, 
        "brief_title": "Oocyte Survival After Vitrification in an Open or Closed Device With Closed Storage.", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Survival", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Donor: \u226436 years old on day of oocyte retrieval\n\n          -  Donor: \u2265 6 mature oocytes\n\n        Exclusion Criteria:\n\n          -  Donor: < 6 mature oocytes"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "36 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01952184", 
            "org_study_id": "2013/777"
        }, 
        "intervention": [
            {
                "arm_group_label": "closed vitrification with closed storage", 
                "intervention_name": "CBSvit HS device", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "open vitrification with closed storage", 
                "intervention_name": "Cryotop SC device", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "vitrification", 
            "oocyte", 
            "donor", 
            "open", 
            "closed"
        ], 
        "lastchanged_date": "September 27, 2013", 
        "location": {
            "contact": {
                "email": "neelke.demunck@uzbrussel.be", 
                "last_name": "Neelke De Munck, MSc.", 
                "phone": "024776694", 
                "phone_ext": "0032"
            }, 
            "facility": {
                "address": {
                    "city": "Jette", 
                    "country": "Belgium", 
                    "state": "Brussels", 
                    "zip": "1090"
                }, 
                "name": "Universitair Ziekenhuis Brussel"
            }, 
            "investigator": {
                "last_name": "Neelke De Munck, MSc.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_arms": "2", 
        "official_title": "Oocyte Survival After Vitrification in an Open or Closed Commercial Device: Study on Sibling Donor Oocytes.", 
        "overall_contact": {
            "email": "neelke.demunck@uzbrussel.be", 
            "last_name": "Neelke De Munck, MSc.", 
            "phone": "024776694", 
            "phone_ext": "0032"
        }, 
        "overall_official": {
            "affiliation": "Centrum voor Reproductieve Geneeskunde, UZBrussel", 
            "last_name": "Neelke De Munck, MSc.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Belgium: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The purpose is to assess the survival rate of donor oocytes with the two vitrification devices.", 
            "measure": "Survival rate", 
            "safety_issue": "No", 
            "time_frame": "up to 6 days after every warming cycle"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01952184"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Universitair Ziekenhuis Brussel", 
            "investigator_full_name": "Neelke De Munck", 
            "investigator_title": "MSc.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "The purpose is to analyse the pre-implantation development of donor oocytes vitrified with two different devices.", 
            "measure": "Embryo development", 
            "safety_issue": "No", 
            "time_frame": "up to 6 days after every warming cycle"
        }, 
        "source": "Universitair Ziekenhuis Brussel", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Universitair Ziekenhuis Brussel", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}